Fabrinet (NYSE:FN) Short Interest Update

Fabrinet (NYSE:FN) saw a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 1,993,192 shares, an increase of 26.6% from the January 29th total of 1,575,002 shares. Based on an average trading volume of 934,390 shares, the short-interest ratio is currently 2.1 days. Currently, 5.6% of the shares of the stock are short sold. Currently, 5.6% of the shares of the stock are short sold. Based on an average trading volume of 934,390 shares, the short-interest ratio is currently 2.1 days.

Institutional Trading of Fabrinet

Institutional investors have recently added to or reduced their stakes in the stock. Azzad Asset Management Inc. ADV acquired a new position in shares of Fabrinet in the 3rd quarter valued at about $1,037,000. Federated Hermes Inc. increased its holdings in Fabrinet by 105.2% in the third quarter. Federated Hermes Inc. now owns 5,982 shares of the technology company’s stock worth $2,181,000 after purchasing an additional 3,067 shares in the last quarter. Torray Investment Partners LLC acquired a new position in Fabrinet in the third quarter valued at approximately $2,458,000. Argent Capital Management LLC bought a new position in shares of Fabrinet during the 3rd quarter worth approximately $4,931,000. Finally, Gateway Investment Advisers LLC bought a new position in shares of Fabrinet during the 3rd quarter worth approximately $1,435,000. 97.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. B. Riley Financial upped their target price on Fabrinet from $366.00 to $452.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 3rd. Needham & Company LLC restated a “buy” rating and set a $540.00 price objective on shares of Fabrinet in a research report on Tuesday, February 3rd. Barclays raised their price objective on Fabrinet from $537.00 to $548.00 and gave the company an “overweight” rating in a research note on Tuesday, February 3rd. Zacks Research upgraded Fabrinet from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 5th. Finally, Susquehanna boosted their target price on Fabrinet from $550.00 to $570.00 and gave the stock a “positive” rating in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Fabrinet presently has a consensus rating of “Moderate Buy” and an average target price of $541.25.

Fabrinet Price Performance

FN opened at $565.93 on Thursday. Fabrinet has a fifty-two week low of $148.55 and a fifty-two week high of $632.99. The company’s 50 day moving average price is $494.37 and its two-hundred day moving average price is $435.33. The firm has a market capitalization of $20.28 billion, a price-to-earnings ratio of 54.21 and a beta of 1.01.

Fabrinet (NYSE:FN) last issued its quarterly earnings results on Monday, February 2nd. The technology company reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.26 by $0.10. The company had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.08 billion. Fabrinet had a net margin of 9.69% and a return on equity of 18.69%. Fabrinet’s revenue was up 35.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.61 earnings per share. Fabrinet has set its Q3 2026 guidance at 3.450-3.600 EPS. As a group, equities research analysts predict that Fabrinet will post 9.4 EPS for the current year.

About Fabrinet

Fabrinet is a global provider of advanced optical packaging and precision optical, electro‐mechanical and electronic manufacturing services (CEM). The company specializes in complex manufacturing processes for original equipment manufacturers (OEMs) in communications, data center, industrial, instrumentation and medical markets. Key capabilities include high‐precision fiber alignment, micro‐assembly, testing and diagnostics, and integration of electro‐optic subassemblies.

Incorporated in 2000, Fabrinet operates under a corporate structure headquartered in Singapore with additional regional offices and design centers in the Americas, Europe and Asia.